CAS 178928-68-2
:NGD 94-1
Description:
NGD 94-1, identified by its CAS number 178928-68-2, is a chemical compound that belongs to a class of substances known for their potential applications in various fields, including pharmaceuticals and materials science. While specific characteristics such as molecular structure, physical properties, and reactivity may vary, compounds in this category often exhibit unique biological activities or functional properties that make them of interest for research and development. Typically, such substances may be evaluated for their solubility, stability, and interaction with biological systems. Additionally, safety and toxicity profiles are crucial for assessing their suitability for use in consumer products or therapeutic applications. As with any chemical, proper handling and adherence to safety guidelines are essential when working with NGD 94-1, particularly in laboratory or industrial settings. For detailed information regarding its specific characteristics, including synthesis methods and applications, consulting scientific literature or material safety data sheets (MSDS) is recommended.
Formula:C18H20N6
InChI:InChI=1/C18H20N6/c1-2-5-15(6-3-1)17-21-13-16(22-17)14-23-9-11-24(12-10-23)18-19-7-4-8-20-18/h1-8,13H,9-12,14H2,(H,21,22)
SMILES:c1ccc(cc1)c1ncc(CN2CCN(CC2)c2ncccn2)[nH]1
Synonyms:- 2-Phenyl-4(5)-((4-(2-pyrimidinyl)-piperazin-1-yl)methyl)imidazole dimaleate
- 2-{4-[(2-phenyl-1H-imidazol-5-yl)methyl]piperazin-1-yl}pyrimidine
- Ngd 94-1
- Ngd-94-1
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Pyrimidine, 2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]-
CAS:Formula:C18H20N6Purity:95%Molecular weight:320.3916NGD 94-1
CAS:<p>NGD 94-1 is a dopamine receptor agonist that is used in the treatment of schizophrenia. It is a potent and selective dopamine D2 receptor agonist that binds to the dopamine D2 receptor with high affinity (Ki = 0.6 nM). NGD 94-1 has been shown to have functional activity as a dopamine D2 receptor agonist in animal models, which may be due to its ability to increase levels of intracellular cyclic AMP and inhibit adenylyl cyclase activity in neuronal tissues.<br>NGD 94-1 has also been found to be effective at reducing the symptoms of schizophrenia in clinical trials, with an effect size that is comparable to other antipsychotic drugs.</p>Formula:C18H20N6Purity:Min. 95%Molecular weight:320.4 g/molNGD 94-1
CAS:NGD 94-1 is a D4 receptor antagonist that can be used to study psychiatric disorders such as cognitive impairment.Formula:C18H20N6Purity:99.61%Color and Shape:SolidMolecular weight:320.39



